Bausch + Lomb Shares Fall Nearly 10% After Interim CEO Appointment
Bausch + Lomb appointed Thomas J. Appio interim CEO, effective immediately, replacing Brent Saunders, as the shares fell nearly 10% Monday. The company and parent Bausch Health said they expect to raise full-year 2026 adjusted EBITDA guidance, but did not disclose revised forecasts.